Corcept Therapeutics Inc (NASDAQ: CORT) on Tuesday, plunged -3.40% from the previous trading day, before settling in for the closing price of $32.67. Within the past 52 weeks, CORT’s price has moved between $20.84 and $35.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 14.14% over the last five years. The company achieved an average annual earnings per share of 2.34%. With a float of $89.78 million, this company’s outstanding shares have now reached $103.41 million.
The firm has a total of 352 workers. Let’s measure their productivity.
Corcept Therapeutics Inc (CORT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Corcept Therapeutics Inc is 13.77%, while institutional ownership is 88.19%. The most recent insider transaction that took place on Jun 03 ’24, was worth 320,000. In this transaction Chief Development Officer of this company sold 10,000 shares at a rate of $32.00, taking the stock ownership to the 6,039 shares. Before that another transaction happened on Jun 03 ’24, when Company’s See Remarks sold 5,000 for $30.18, making the entire transaction worth $150,916. This insider now owns 7,314 shares in total.
Corcept Therapeutics Inc (CORT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 2.34% per share during the next fiscal year.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
Corcept Therapeutics Inc (CORT) is currently performing well based on its current performance indicators. A quick ratio of 5.10 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.28. Likewise, its price to free cash flow for the trailing twelve months is 26.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.06, a number that is poised to hit 0.23 in the next quarter and is forecasted to reach 1.35 in one year’s time.
Technical Analysis of Corcept Therapeutics Inc (CORT)
Analysing the last 5-days average volume posted by the [Corcept Therapeutics Inc, CORT], we can find that recorded value of 1.07 million was lower than the volume posted last year of 1.38 million. As of the previous 9 days, the stock’s Stochastic %D was 78.99%. Additionally, its Average True Range was 1.47.
During the past 100 days, Corcept Therapeutics Inc’s (CORT) raw stochastic average was set at 74.55%, which indicates a significant increase from 62.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.05% in the past 14 days, which was higher than the 49.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.54, while its 200-day Moving Average is $26.56. Now, the first resistance to watch is $32.49. This is followed by the second major resistance level at $33.41. The third major resistance level sits at $33.90. If the price goes on to break the first support level at $31.08, it is likely to go to the next support level at $30.59. Now, if the price goes above the second support level, the third support stands at $29.67.
Corcept Therapeutics Inc (NASDAQ: CORT) Key Stats
Market capitalization of the company is 3.29 billion based on 104,110K outstanding shares. Right now, sales total 482,380 K and income totals 106,140 K. The company made 146,810 K in profit during its latest quarter, and 27,760 K in sales during its previous quarter.
